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It is challenging to discuss the use of high-risk organs with patients, in part because of the lack of information about how
patients view this topic. This study was designed to determine how patients think about organ quality and to test formats for
risk communication. Semistructured interviews of 10 patients on the waiting list revealed limited understanding about the
spectrum of organ quality and a reluctance to consider anything but the best organs. A computerized quantitative survey
was then conducted with an interactive graph to elicit the risk of graft failure that patients would accept. Fifty-eight percent
of the 95 wait-listed patients who completed the survey would accept only organs with a risk of graft failure of 25% or less
at 3 years, whereas 18% would accept only organs with the lowest risk possible (19% at 3 years). Risk tolerance was
increased when the organ quality was presented relative to average organs rather than the best organs and when feedback
was provided about the implications for organ availability. More than three-quarters of the patients reported that they wanted
an equal or dominant role in organ acceptance decisions. Men tended to prefer lower risk organs (mean acceptable risk ¼
29%) in comparison with women (mean acceptable risk ¼ 35%, P ¼ 0.04), but risk tolerance was not associated with other
demographic or clinical characteristics (eg, the severity of liver disease). In summary, patients want to be involved in deci-
sions about organ quality. Patients’ risk tolerance varies widely, and their acceptance of high-risk organs can be facilitated if
we present the risks of graft failure with respect to average organs and provide feedback about the implications for organ
availability. Liver Transpl 17:1387–1393, 2011. VC 2011 AASLD.
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Deceased donor liver allografts vary widely in quality. Do-
nor characteristics such as age, cause of death, steatosis,
and ischemia time can make the difference between 20%
and 40% rates of graft failure 3 years after transplanta-
tion.1 Furthermore, organ quality appears likely to worsen
in the future. The donor pool is aging, more donors have
experienced stroke as the cause of brain death, and the
federally funded Organ Donation Breakthrough Collabora-
tive is promoting the expansion of the donor pool with
extended criteria donor (ECD) organs, which carry higher
risks of graft failure.2 Thus, issues of organ quality are
increasingly relevant for every liver transplant candidate.
Each time that an organ offer is made, the patient
and physician are faced with a difﬁcult choice: to
accept the offer or to wait in the hope that a better
one will come along. For patients with end-stage liver
disease, this decision could mean the difference
between life and death. For physicians, this decision
is fraught with uncertainty and requires the balancing
of numerous patient and donor factors. Furthermore,
communicating this complex risk/beneﬁt tradeoff to
the patient can be challenging. Ideally, discussions
about organ quality should occur prospectively during
the transplant evaluation.3 However, this is easier
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said than done in a busy transplant clinic. These dis-
cussions are made even more difﬁcult by our limited
understanding of how patients perceive organ quality.
How much risk of graft failure are patients willing to
accept, and what factors inﬂuence their decisions?
What are the critical knowledge deﬁcits and cognitive
biases that must be addressed in physician-patient
conversations?
In this study, we investigated how candidates for
liver transplantation consider issues of organ quality.
In addition to presenting an overview of patients’ deci-
sion-making process, we aimed to (1) test various pre-
sentation formats for communicating risks to patients
and (2) determine which patient factors might be
associated with an increased willingness to accept
higher risk organs.
PATIENTS AND METHODS
Because of the limited prior knowledge about this
subject, we employed a mixed methods approach con-
sisting of qualitative and quantitative components.4
These methods are complementary: qualitative data
are richer and more nuanced and allow the detection
of ﬁndings that do not necessarily ﬁt with researchers’
preconceived notions or hypotheses. Quantitative
data, on the other hand, allow the testing of speciﬁc
inferential hypotheses.
Both portions of the study were performed with
adult patients at a transplant clinic who were already
on the waiting list for liver transplantation. At our
center, all patients receive an extensive education
about the transplant system, including a half-day
group education class, before their placement on the
waiting list. Additionally, each patient has at least 1
individual appointment with a transplant surgeon,
who routinely discusses the topic of organ quality.
Speciﬁcally, at each of these appointments, the sur-
geon explains that organ quality is on a spectrum
and describes organs with a higher than average risk
of graft failure (eg, donation after cardiac death
organs).
Qualitative Methods
Semistructured interviews of adult patients on the
waiting list for liver transplantation at our center were
conducted by the primary author (M.L.V.). The
patients were enrolled from the transplant clinic; the
exclusion criteria were signiﬁcant hepatic encephalop-
athy (West Haven grade 2 or higher) and an inability
to converse in English. This study was approved by
our institutional review board, and informed consent
was obtained for the interviews and audio recording.
The questions were initially open-ended but progres-
sively grew more focused on patients’ understanding
of organ quality and preferences for accepting higher
risk organs. Probes were used to elicit further details.
The interviews also included questions about patients’
perceptions of their risk of dying on the waiting list
and their opinions about the organ allocation system.
The interviews were recorded, transcribed, and
imported into NVivo 7 (QSR International, Doncaster,
Australia), which is a qualitative data analysis pack-
age allowing the manipulation and organization of
text from transcripts. The analysis was performed
with methods of qualitative description.5 First, codes
representing analytically meaningful categories were
assigned to segments of the text. Second, these seg-
ments were organized together so that patterns and
themes could emerge. Interviews were conducted until
the transcripts no longer revealed new and relevant
information.
Quantitative Methods
The ﬁndings from the qualitative portion of the study
were then used to inform the development of a quanti-
tative Web-based patient survey. Patients on the wait-
ing list for liver transplantation were enrolled from the
transplant clinic to complete the survey on a study
laptop computer. Patients with limited computer liter-
acy were assisted by a study coordinator who was
trained in survey administration. Those with signiﬁ-
cant hepatic encephalopathy were excluded, as were
subjects from the qualitative portion of the study.
Among those approached, the participation rate was
82%. Informed consent was obtained from all sub-
jects, and the entire protocol was approved by the
institutional review board.
The survey consisted of 3 sections: (1) education
about the spectrum of organ quality and the implica-
tions of graft failure, (2) the elicitation of patient pref-
erences about the level of graft failure risk that they
would accept, and (3) the covariates hypothesized to
inﬂuence patient decisions. These covariates included
the following:
1. Demographic and clinical characteristics, which
included the Model for End-Stage Liver Disease
(MELD) score.
2. Patients’ quality of life, which was measured
with a visual analogue scale.6
3. Patients’ belief in control over their own health,
which was measured with a validated scale
called Locus of Control and has been shown in
other ﬁelds to affect risk-taking behavior.7
4. A validated scale measuring trust in
physicians.8
5. Patients’ knowledge of the MELD-based alloca-
tion system, which was measured by the per-
centage of correctly answered questions.
6. Patients’ estimates of their risk of dying in the
next 3 months on the waiting list for
transplantation.
7. Patients’ estimates of the probability of receiv-
ing a transplant in the next 3 months.
8. Patients’ expectations about their survival and
quality of life after transplantation.
9. Patients’ emotional distress due to waiting for
an organ, which was measured with a
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standardized scale called the Positive and Nega-
tive Affect Schedule.9
10. A validated scale of numeracy, which reﬂected
patients’ comfort and ability to work with num-
bers (similar to the concept of literacy).10
To elicit patient preferences, patients were
instructed to imagine being offered a transplant right
then and were asked to indicate what risk of graft fail-
ure at 3 years they would be willing to accept.
Responses were recorded with an interactive graphical
tool that visually represented in a pictograph format
how many organs out of 100 would fail. An example
of this preference elicitation tool is shown in Fig. 1.
The pictograph format was chosen because picto-
graphs have been shown to improve the understand-
ing of risk information in other clinical settings.11,12
With a computerized random number generator,
patients were randomized to receive 2 different ver-
sions of this elicitation tool: in one version, the initial
pictograph showed the risk of graft failure with the
best quality organs (19% at 3 years), and in the other
version, the initial pictograph showed the risk of graft
failure with average quality organs (25% at 3 years).
This randomization was performed to determine
whether the patients’ responses were anchored to the
initial graph that they saw. After the initial preference
elicitation, the patients were provided feedback about
how their preferences would limit the number of
organs available to them (see the pie chart in Fig. 1,
which was not visible in the initial elicitation). They
were then asked whether they would like to revise
their answers; data were collected before and after the
feedback to determine whether this feedback inﬂu-
enced preferences.
Finally, a possible bias against lower quality organs
was tested by the presentation of a discrete choice
scenario with a logically correct answer: (1) staying on
the waiting list with a 20% risk of dying or (2) accept-
ing a lower quality liver with a 20% risk of dying but
an improved quality of life.
The statistical analysis was performed with non-
parametric methods because the preliminary analysis
of the data revealed that the patient preferences did
not ﬁt a normal distribution, and linear residuals
demonstrated signiﬁcant heteroskedasticity. A Spear-
man correlation was used for interval independent
variables, a Mann-Whitney test was used for dichoto-
mous independent variables, and a Wilcoxon signed-
rank test was used for paired samples. Because of the
exploratory nature of this analysis and the relatively
few predictors of subject preferences on bivariate test-
ing, a multivariate regression was not performed. Cal-
culations were performed with Stata/SE 11.0 (Stata-
Corp, College Station TX). The required sample for
detecting medium-sized associations between patient
factors and preferences for organ quality was 84 sub-
jects when b ¼ 0.8 and 2-tailed a ¼ 0.05 were
assumed.13
Finally, we re-approached 20 patients who had
remained on the waiting list and had taken the initial
survey at least 6 months previously to determine
whether their preferences remained stable over time.
Figure 1. Tool for eliciting patient preferences about the risk of graft failure.
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During this period, we continued to recruit new par-
ticipants; thus, our ﬁnal sample size was 95 subjects.
RESULTS
Qualitative Results
Several themes became apparent after 10 wait-listed
patients (4 men and 6 women) were interviewed (me-
dian MELD score ¼ 14). First, even though they had
received a prelisting education about the spectrum of
organ quality, these wait-listed patients had a very
poor understanding of the subject. They attempted to
dichotomize organs into good and bad ones, and they
assumed that any organ that they would be offered
would be good: ‘‘They’re not going to offer it if it’s not
transplantable,’’ and ‘‘Just knowing this hospital and
its reputation, I would think they would be looking
only at good quality organs.’’ This view was even held
by a patient who had previously been called for a
transplant that was canceled because of concerns
about the organ quality. Despite this experience, she
indicated that when she was offered another one, ‘‘I’m
sure it will be good—we should be checking them out
ﬁrst.’’ Most patients were initially resistant to receiv-
ing anything but the best quality organ: ‘‘Well, I’d like
to get a liver from an 18-year-old football player’’; ‘‘I
would think that 5% risk [of graft failure] would be
the norm, but I’m not sure I would want more than
that’’; and ‘‘If I’m going to be sliced and diced, I’d
rather get something that will last me a long time.’’
These qualitative ﬁndings affected the design of the
quantitative survey and led speciﬁcally to the empha-
sis on the spectrum of organ quality and the testing of
methods for mitigating patients’ initial biases.
Quantitative Results
Demographic characteristics are shown in Table 1 for
the 95 wait-listed patients who participated in this
portion of the study. The median age was 55 years,
65% were male, and the median MELD score was 13.
The mean laboratory MELD score was slightly lower
for the participants versus our overall wait-listed pop-
ulation (13 versus 15, P < 0.001), and the partici-
pants were less likely to be Hispanic (1% versus 7%, P
¼ 0.02); however, the other demographic characteris-
tics were representative.
The results for the various psychological metrics are
shown in Table 2, which provides an overview of the
group’s mental and emotional states at the time of the
survey. The patients’ numeracy was similar to that of
TABLE 1. Demographic Characteristics of the 95
Wait-Listed Patients in the Quantitative Study
Median age (years) 55 (19-70)
Male sex (%) 65
Race/ethnicity (%)
White 87
Black 9
Hispanic 1
Other 3
Median laboratory MELD score 13 (6-23)
Hepatocellular carcinoma exception (%) 8
Primary diagnosis (%)
Alcohol 18
Viral 29
Cryptogenic/fatty liver 22
Other 31
NOTE: Ranges are shown in parentheses.
TABLE 2. Results of Psychological Metrics
Metric Median Score Interpretation/Comment
Numeracy 4.2 The scale goes from 1 to 6; the scores were similar
to those of other populations.
Positive and Negative Affect Schedule 4 The scale goes from 27 to þ27; positive values
reﬂect more positive feelings than negative feelings.
Quality-of-life visual analogue 65 The scale goes from 0 to 100; the results reﬂect
moderate impairment in the quality of life.
Perceived risk of dying on the waiting
list in the next 3 months
5% (0%-80%) Patients perceived a low chance of death on the
waiting list.
Perceived chance of receiving a transplant
in the next 3 months
10% (0%-100%) Patients perceived a slightly higher chance of
transplantation.
Trust in physicians 5 The scale goes from 1 to 6; the results reﬂect high
trust in physicians.
Knowledge Correct answers
to 67% of the items
97% understood that their MELD score inﬂuenced
their chance of transplantation; only 67% knew this
about their willingness to accept high-risk organs.
Locus of Control 4 The scale goes from 1 to 6; scores greater than 3
reﬂect the perception that health is not within the
patient’s control.
NOTE: Higher scores reﬂect better numeracy, more positive affect, better quality of life, more trust, more external locus of
control, and so forth. Ranges are shown in parentheses.
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the general population with a median score of 4.2 on
a 1 to 6 scale.10 Their affect was on the positive end
of the spectrum with a median score of 4 on a 27 to
þ27 scale. Their quality of life was moderately
impaired with a median score of 65 on a 0 to 100 ana-
logue scale. Eighty percent of the patients expected
that their quality of life would improve after trans-
plantation by a median of 15 points. They perceived a
relatively low chance of dying on the waiting list in the
next 3 months (median risk ¼ 5%, range ¼ 0%-80%)
and believed that they had a 10% chance (median;
range ¼ 0%-100%) of receiving a transplant in the
next 3 months. Their trust in physicians was high
with a median score of 5 on a 1 to 6 scale. They cor-
rectly answered 67% of knowledge questions about
factors that would inﬂuence their chances of receiving
a transplant. In particular, 97% understood that their
MELD score would inﬂuence their chance of trans-
plantation, whereas only 67% responded that their
chances would be inﬂuenced by the quality of the
organ that they were willing to accept. Finally, this
group had a relatively external locus of control with a
median score of 4 on a 1 to 6 scale (the higher num-
ber reﬂected their belief that their health was outside
their control).
Risk Preferences
After the patients had completed the preference elici-
tation tool, the mean risk of graft failure that they
were willing to accept for a particular organ was 32%
3 years after transplantation. There was signiﬁcant
between-patient variability in risk preferences, as
shown in Fig. 2. The majority of the patients preferred
relatively low-risk organs: despite feedback that strin-
gent acceptance criteria could shrink the pool of
organs available to them, 58% would accept only
organs with a risk of graft failure of 25% or less at 3
years, whereas 18% would accept only organs with
the lowest risk possible (19% at 3 years). A bias
against lower quality organs was demonstrated by
their responses to the following scenario: subjects
were asked to choose between (1) continuing on the
waiting list with a 20% chance of dying and (2)
accepting a lower quality liver with a 20% chance of
dying but an improved quality of life. In this discrete
choice scenario with a logically correct answer
(accepting the liver), 42% preferred to stay on the
waiting list. Nonetheless, a sizable minority were will-
ing to accept much higher risks, up to nearly 100% in
some cases, in order to receive a transplant. Patients
reported a strong desire to be involved in decisions
about organ acceptance, with 83% wanting an equal
or dominant role in the decision.
Among the 20 patients re-approached after a mean
of 16 months (range ¼ 6-30 months), the group’s risk
preferences were not signiﬁcantly different [the mean
acceptable graft failure risk was 34% on the initial sur-
vey and 33% on re-approach (P ¼ 0.3)]. However, the
individual preferences were not particularly stable,
and there was only a modest correlation between the
initial and re-approach values (Spearman’s q ¼ 0.24).
Changes in preferences were not associated with either
changes in the MELD score (which increased by a
mean of 1 point in this group; P ¼ 0.1) or the time from
the initial survey to re-approach (P ¼ 0.9).
Impact of the Presentation Format
The format for presenting information did have a sig-
niﬁcant impact on patient preferences. The absolute
risk of graft failure that patients were willing to accept
was modiﬁed by the initial graphical presentation;
those initially shown a graph with a 19% risk of graft
failure (the best organ scenario) would accept up to a
26% risk on average, whereas those initially shown a
graph with a 25% risk of graft failure (the average
organ scenario) would accept up to a 29% risk on av-
erage (P ¼ 0.001). This experiment demonstrated the
psychological bias of anchoring to the initial number
seen. Patients were also inﬂuenced by feedback about
organ availability. During the initial preference elicita-
tion, the mean risk of graft failure at 3 years that
patients were willing to accept was 28%; this
increased to 32% once they were given pie chart feed-
back (as shown in Fig. 1; P ¼ 0.003). Among the 67
patients who initially preferred organs with no more
than a 25% 3-year risk of graft failure, 13 (19%) indi-
cated that they would accept a risk greater than 25%
after they had received this feedback. Conversely,
among the 28 patients who initially would accept
organs with more than a 25% 3-year risk of graft fail-
ure, only 2 (7%) reduced their risk tolerance after they
had received the feedback.
Correlates of Risk Preferences
Among the patient demographics and clinical charac-
teristics, only sex was associated with risk preferen-
ces, with men preferring lower risk organs in compari-
son with women (the 3-year graft failure risk tolerance
Figure 2. Histogram demonstrating the variability between
patients in terms of the 3-year risk of graft failure that they were
willing to accept (n ¼ 95). The displayed preferences are those
stated by patients after they had the opportunity to reflect upon
the implications of organ availability (see the pie chart in Fig. 1).
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after feedback was 29% for men and 35% for women;
P ¼ 0.04). In particular, neither laboratory MELD
scores nor MELD exceptions for hepatocellular carci-
noma were signiﬁcantly associated with their risk
preferences (P ¼ 0.2 and P ¼ 0.1, respectively), nor
were their perceived chances of dying or getting a
transplant. Among the psychological factors hypothe-
sized to correlate with patient risk preferences, only
the belief in control over one’s health demonstrated a
statistically signiﬁcant association: patients with more
external locus of control were more likely to accept
higher risk organs (P ¼ 0.04). When patients were
asked directly what factors would inﬂuence their deci-
sions about organ acceptance, the most common
response was quality of life (85%), and this was fol-
lowed by trust in the transplant team (79%).
DISCUSSION
This study of patient decision making about organ
quality in liver transplantation has 3 main ﬁndings.
First, many patients entered discussions about organ
quality with an inherent bias against the acceptance
of organs with higher risks of graft failure. This ﬁnd-
ing was demonstrated most clearly by their responses
to the discrete choice scenario: 42% would choose to
stay on the waiting list instead of accepting a lower
quality liver that would improve their quality of life
and would not increase their chance of dying. This
bias against lower quality organs was partially miti-
gated when the organ quality was presented with
respect to average organs rather than the best organs
and when feedback was provided about the implica-
tions for organ availability. Second, risk tolerance was
highly variable between individuals and was not par-
ticularly stable over time. Third, an individual
patient’s risk tolerance was associated with sex and
beliefs about control over his or her health and not
with the severity of liver disease. Although these ﬁnd-
ings need to be conﬁrmed in future studies, they pro-
vide much needed information about ways to counsel
patients about issues of organ quality.
How involved should patients be in decisions about
organ acceptance? Some would argue that this deci-
sion is too complicated for patients to contemplate.
On the contrary, we contend that patient involvement
is important for many reasons. First, from an ethical
standpoint, few would dispute that patients have the
right to know the quality of the organs that they are
receiving.3 Physicians routinely counsel patients
about risks and beneﬁts of medications and proce-
dures, and organ quality should be no different. Sec-
ond, from a legal standpoint, there may be ramiﬁca-
tions for transplant centers that do not adequately
inform their patients.3 Third, from the standpoint of
outcomes, patient involvement in decision making is
associated with improved survival14 and improved
medication compliance in the setting of renal trans-
plantation.15 Finally, the patients want to be involved.
In our study, 83% of the patients reported that they
would prefer an equal or even dominant role in decid-
ing whether to accept a higher risk organ. Thus, it is
incumbent upon the transplant community to respect
the autonomy of patients by involving them in these
discussions.
Despite these arguments, a number of logistical
challenges remain. First, although general issues of
organ quality can and should be discussed in
advance,16 the real decision happens when an organ
offer is made. This event often occurs in the middle of
the night under less than ideal circumstances for
informed consent discussions. Second, although the
primary decision should focus on risks and beneﬁts for
the individual patients, transplant physicians must
also consider the impact on other patients on the wait-
ing list, which can at times pose an ethical dilemma.
Third, ﬁndings from our study suggest that patient
preferences are signiﬁcantly inﬂuenced by the presen-
tation format and are relatively unstable over time.
Thus, we do not recommend that patients simply be
asked to decide on their own (nor do patients want
this). Instead, we suggest that patients be guided
through the decision and provided with a clear recom-
mendation that they can then accept or reject. Fur-
thermore, the preferences of patients will need to be
readdressed frequently as their clinical condition
changes. We are currently in the process of developing
a patient education tool for this purpose, and we are
building upon our ﬁndings in this study as well as pre-
vious work demonstrating that complex risk communi-
cation is best done (1) with graphs, (2) with absolute
risks rather than relative risks, and (3) with contextual
information (to account for innumeracy).17-19 This
education tool is intended as something that patients
can use at home; in this way, it will not interfere with
the ﬂow at a busy transplant clinic but can set the
stage when the actual organ offer occurs.
This study was limited by its single-center nature
and the inclusion of relatively few patients with very
high MELD scores. The unstable nature of high-
MELD patients provided logistical challenges for their
enrollment: they often missed clinic appointments
because they were admitted to the hospital, and they
either died or received a transplant quickly. Therefore,
the ﬁndings in this study cannot necessarily be gener-
alized to patients with different sociodemographic
characteristics and more severe liver disease. Another
limitation was the use of a preference elicitation tool
that had not been previously validated. When this
study was begun in 2008, no literature existed on this
topic in liver transplantation. Recently, another group
conducted a study on patients’ willingness to accept
ECD organs.20 Although that study dichotomized
organs into standard organs and ECD organs, the
authors found similar results: a large proportion of
patients expressed a reluctance to consider ECD
organs. The strengths of our study included the mixed
methods approach and the testing of various presen-
tation formats. These design features allowed us to
develop an understanding of the best ways to commu-
nicate with patients instead of simply describing their
preferences. Finally, it is important to note that both
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of these studies focused on organ-speciﬁc risks of
graft failure and not disease transmission. The litera-
ture for kidney transplantation suggests that patients
have similar biases about disease transmission
risks.21,22
In summary, our patients expressed a strong desire
to be involved in decisions about organ quality and
demonstrated widely varying levels of risk tolerance.
We found that risk tolerance was not associated with
disease severity, but it was signiﬁcantly inﬂuenced by
the presentation format. These ﬁndings suggest that
when organ quality is being discussed with patients,
the risks of graft failure should be presented with
respect to average quality organs, and feedback
should be provided about the relationship between
organ quality and availability. Future work on devel-
oping validated patient education tools will aid trans-
plant physicians in these discussions.
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